10 Facts About Ortho Pharmaceutical

In 1963, Ortho Pharmaceutical introduced the second oral contraceptive available in the United States.

In 1964, Ortho Pharmaceutical bought rights to and marketed the Gynekoil and Lippes Loop inert plastic IUDs in the United States until the mid-1970s and 1985, respectively.

In 1968, Ortho Pharmaceutical introduced RhoGAM Rho immune globulin, the first medication developed to prevent Rh hemolytic disease of the newborn.

In 1989, the FDA approved Ortho Pharmaceutical Cyclen containing the first new progestin approved in over 20 years in the United States.

In 1992, Ortho Pharmaceutical introduced Ortho Pharmaceutical Tri-Cyclen in the United States, which in 1996 became the first oral contraceptive with an FDA-approved non-contraceptive indication.

Related searches

From 1995 to 2003, Ortho Pharmaceutical marketed the ParaGard copper T-380A IUD in the United States.

In 2001, Ortho Pharmaceutical introduced the Ortho Pharmaceutical Evra transdermal contraceptive patch in the United States.

In 1993, Ortho Pharmaceutical merged with McNeil Pharmaceutical in 1993 to form Ortho-McNeil Pharmaceutical.

Ortho Pharmaceutical started with one product and three employees and it was one of the first companies in Canada to make oral contraceptives.

Ortho Pharmaceutical Canada merged with McNeil Pharmaceutical Canada in 1991, and merged with Janssen Pharmaceutica Canada in 1995 to form Janssen-Ortho.